Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Aug 2026

Targeted Therapy and Immunotherapy are Novel Treatment Plans of Hepatocellular Carcinoma that is not Amenable to Surgical Resection: Emerging Trends in Combined Treatment Strategies

Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality worldwide, with advanced unresectable disease presenting a significant therapeutic challenge. The treatment paradigm has undergone a fundamental transformation, shifting from tyrosine kinase inhibitor (TKI) monotherapy to combination str...

Gaoxiong Tan, Wen-Yong Feng, De-Ren Yang et al. · 0 citations
Review Open access Sep 2026

ALKBH5 inhibitors for cancer therapy: molecular docking, challenges and future prospects

N 6 -Methyladenosine (m 6 A), the most abundant internal modification of eukaryotic mRNA, is dynamically reversed by the Fe II /α-ketoglutarate-dependent dioxygenase ALKBH5, a key m 6 A “eraser” that regulates target mRNA fate through demethylation. ALKBH5 is aberrantly overexpressed in acute myeloid leukemia...

Chen Deng, Hai Xu, Jian Pu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.